BP-lowering medication should not be used in normotensive primary prevention population at intermediate CV risk
Media formats available:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
- ESC Congress 2024
Main messages of the 2024 ESC hypertension guidelines
Keith Churchwell, MD
Ricky Turgeon, PharmD
Florian Rader, MD
Michael Bloch, MD